
Oncologist

No OPD information available
Melanoma
Melanoma of the Eye
Uveal Melanoma
Lung Metastases
Merkel Cell Carcinoma
Mosaicism
Neuroendocrine Tumor
Retinal Artery Occlusion
Mark J. Shackleton is a male medical professional who specializes in treating various conditions such as melanoma, melanoma of the eye, uveal melanoma, lung metastases, Merkel cell carcinoma, mosaicism, neuroendocrine tumor, and retinal artery occlusion.
Mark J. Shackleton helps patients by providing specialized care for these conditions. He uses his expertise and skills to diagnose and treat patients effectively. Patients trust him because he communicates clearly and compassionately, making sure they understand their treatment options and feel supported throughout their medical journey.
To stay updated with the latest medical knowledge and research, Mark J. Shackleton regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This dedication to learning ensures that he can offer the most advanced and effective treatments to his patients.
Mark J. Shackleton works closely with colleagues and other medical professionals to provide comprehensive care to patients. He values teamwork and believes that by working together, they can achieve the best outcomes for their patients.
Through his work, Mark J. Shackleton has made a positive impact on many patients' lives by improving their health outcomes and quality of life. His dedication to his patients and his commitment to providing excellent care have earned him the trust and gratitude of those he treats.
One of Mark J. Shackleton's notable publications is "Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years," published in JHLT open on March 27, 2025. He is also involved in a clinical trial titled "A Randomised, Placebo-controlled, Phase II Trial of Adjuvant Avelumab in Patients With Stage I-III Merkel Cell Carcinoma," which is currently active but not recruiting participants.
In summary, Mark J. Shackleton is a dedicated and skilled medical professional who goes above and beyond to provide exceptional care to his patients and contribute to advancements in the field of medicine.
Enrollment Status: Active not recruiting
Published: April 03, 2025
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 2
